Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia

PLoS Medicine(2022)10.1371/journal.pmed.1004049Source: DataRank Database

Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia is a research paper published in PLoS Medicine (2022). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 2.78)OA: goldTopics (85)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (3)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Dan Lewer ORCID,N. R. Jones ORCID,Samantha Colledge‐Frisby ORCID,Michael Farrell ORCID,Matthew Hickman ORCID

Live enrichment

PubMed:35853024 PMC:PMC9295981 OpenAlex:https://openalex.org/W4285798360

Dalhousie University Internal Medicine Research Foundation

Grant: Fellowship

Faculty of Medicine, Dalhousie University

Grant: Killam Postgraduate Scholarship, Ross Stewart Smith Memorial Fellowship in Medical Research, Clinician Investigator Program Graduate Stipend

Canadian Institutes of Health Research

Grant: CIHR-FRN 171259

National Institute on Drug Abuse

Grant: R25DA033211

National Institute on Drug Abuse

Grant: R25DA013582

National Institute for Health Research

Grant: DRF-2018–11-ST2-016

University of New South Wales

Grant: Scientia PhD Scholarship

National Health and Medical Research Council

Grant: PhD Scholarship

National Health and Medical Research Council

Grant: 1135991

Increasing knowledge about substance use, mental health and harms, and interventions to prevent and reduce harm

National Institute on Drug Abuse

Grant: R01DA044740

Australian Government Department of Health

Grant: Drug and Alcohol Program

Medical Research Council

Grant: MR/N00616X/1

NIDA NIH HHS

Grant: R34 DA044740

CIHR

Grant: FRN 171259

National Institute for Health Research (NIHR)

Grant: DRF-2018-11-ST2-016

National Institute for Health Research (NIHR)

Grant: NIHR202393

National Institutes of Health

Grant: 4R25DA033211-04

Advancing Clinical Research Training within Addiction Residency Programs

National Institutes of Health

Grant: 5R34DA044740-03

Testing a System-level Implementation Intervention to Improve the Quality of Family-Based Services for Adolescent Substance Use

National Institutes of Health

Grant: 5R25DA013582-08

Clinical Addiction Research and Education (CARE) Program

Canadian Institutes of Health Research

Grant: unidentified

unidentified

FWCI

2.78

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1371/journal.pmed.1004049

publisherhttps://doi.org/10.1371/journal.pmed.1004049

publisherhttps://dx.plos.org/10.1371/journal.pmed.1004049

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35853024

repositoryhttp://hdl.handle.net/1959.4/unsworks_80966

Fields of Study

HIV, Drug Use, Sexual RiskOpioid Use Disorder TreatmentAntifungal resistance and susceptibility03 medical and health sciences0302 clinical medicine0305 other medical scienceAdultAnalgesics, OpioidAustraliaBacteremiaCohort StudiesEndocarditisFemaleHumansMaleMycosesNew South WalesOpiate Substitution TreatmentSepsisSubstance Abuse, Intravenous

MeSH Terms

AdultAnalgesics, OpioidAustraliaEndocarditisFemaleHumansMaleMycosesNew South WalesCohort StudiesSubstance Abuse, IntravenousBacteremiaSepsisOpiate Substitution Treatment

Keywords

MedicineHazard ratioBuprenorphineBacteremiaSepsisCohortInternal medicineProportional hazards modelEndocarditisCohort studyInterquartile rangeMethadoneConfidence intervalSurgeryOpioidAntibioticsAnesthesiaAdultMale61032 Biomedical and Clinical SciencesCohort StudiesSubstance Misuseanzsrc-for: 32 Biomedical and Clinical Sciences615Opiate Substitution Treatment2.2 Factors relating to the physical environmentHumansSubstance Abuse, Intravenous3202 Clinical SciencesAnalgesicsanzsrc-for: 42 Health sciencesOpioid Misuse and AddictionSubstance AbuseRAustralia3 Good Health and Well BeingHematologyOpioidsAnalgesics, OpioidInfectious Diseasesanzsrc-for: 11 Medical and Health SciencesMycoses6.1 Pharmaceuticalsanzsrc-for: 3202 Clinical SciencesFemaleNew South WalesDrug Abuse (NIDA only)InfectionIntravenousResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 16: 16. Peace & justiceSDG 0: Good health and well-being

Opioid agonist treatment and risk of death or rehospitalization following injection drug use–associated bacterial and fungal infections: A cohort study in New South Wales, Australia

FAIR Checklist

Authors (9)

Funding (20 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)